ZTEKFOTCMiscellaneous Chemical ProductsFiscal year ends March 31
Zentek Ltd.
Financials through fiscal 2025, year ended Mar 31, 2025Last filing: 40-F on Jun 25, 2026
$0.41−0.04 (-8.10%)
Close on Oct 19, 2026
Margins
Share of revenue, fiscal years 2021 to 2025
Operating margin
–
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|
Returns and balance sheet
5 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2021 | FY2021 | FY2025 | Trend |
|---|---|---|---|---|
| Current ratio | 1.35 | 1.35 | 1.25 | |
| Net debt to EBITDA | – | – | -0.03× | |
| Interest coverage | -667.8× | -667.8× | -105.2× | |
| Capex to revenue | 10797.5% | 10797.5% | – | |
| Diluted shares | 84M | 84M | 103M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Zentek generated C$37.07M from operations and spent C$6.83M on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
C$37.07M
Used
C$6.83M
Capital expenditureC$6.83M100%DividendsC$00%Share buybacksC$00%
DuPont needs revenue, assets and equity
This company does not report all three for consecutive years.
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
1of 4 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero–
- Cash generatingOperating cash flow above zero-C$6.28M
- Return on assets improvedROA up on the prior year– → –
- Earnings backed by cashOperating cash flow above net income-C$6.28M vs –
- Less leverageLong-term debt to assets fell1.1% → 0.0%
- Better liquidityCurrent ratio rose3.44 → 1.25
- No dilutionShare count did not rise101M → 103M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose– → –